Hadar Avihai Lev-Tov, MD, advocates for a holistic approach to wound care, emphasizing that chronic ulcers often signal underlying systemic health issues requiring a comprehensive patient assessment to achieve effective and potentially life-saving treatment.
Hadar Avihai Lev-Tov, MD, associate professor of clinical dermatology and cutaneous surgery at the University of Miami Health System, emphasizes a holistic approach to wound care, especially for patients with comorbidities like diabetes or peripheral vascular disease.
He stresses that a chronic, nonhealing ulcer is often a symptom of an underlying systemic issue, not just a localized problem. By considering what might be "missing" in the patient's overall health, dermatologists can make accurate diagnoses and initiate appropriate treatments that, in some cases, can be life-saving. This perspective highlights the critical need for comprehensive patient assessment in wound management to ensure effective healing and improved patient outcomes.
This transcript was lightly edited; captions were auto-generated.
Transcript
How do you approach managing wound care for patients with comorbidities to ensure comprehensive care?
We like to say in wound care that you have to remember that there's a patient around the hole in the patient. Besides the wound, the wound is actually telling you something else is going on on the inside, and that's true for a lot of dermatology, but especially in wounds.
If you are encountering a chronic ulcer that is not healing, you have to remember that it came from somewhere. Something is wrong with the patient, and the most common things that we see are chronic venous insufficiency or diabetes, but there are other rare conditions that may be even life-threatening that you can save a life. When you see a chronic wound and you're unsure what is happening, you have to always consider, what am I missing? What is happening under the skin that can make this wound happen? Then you can really make a good diagnosis and start the right treatment that can sometimes even save a life.
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More